Min Liu

Min Liu

Auto-generated profile, based on publicly available information

Min Liu

Emergency Medicine Clinical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, & Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Clinical Center for Medicine in Acute Infection, Capital Medical University, Beijing, People's Republic of China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2021 in Primary Health Care Research & Development
Verified
Journal Article
Open access
PDF file
MLMin Liu
Min Liu
ZGZhenlei Gao
Zhenlei Gao
XZXuelei Zhang
Xuelei Zhang
XYXiaoxu Yuan
Xiaoxu Yuan
YLYuewu Lu
Yuewu Lu
JMJuan Meng
Juan Meng
Background: The incidence of gout has increased rapidly in recent years, and the suspected lack of awareness of gout among general practitioners may lead to misdiagnosis and inappropriate treatment. Aim: To assess general practitioners’ management of gout at community health service clinics in the Tongzhou district of Beijing, as well as the factors that contributed to optimal decision making. Methods: A survey based on current guidelines for assessment and management of gout was sent to 245 general practitioners at community health service clinics in the Tongzhou district of Beijing. The questionnaire included personal information of general practitioners and ten items that addressed knowledge of gout. Our questionnaire was self-administered and distributed electronically via WeChat, and data were collected on a platform called ‘Wenjuanwang’. Statistical analysis was performed using SPSS version 19.0 software. Results: Totally, 216 general practitioners responded to the survey. About three-quarters (71.8%) reported having received Continuing Medical Education (CME) about gout. More than half (54.6%) reported an awareness of treat to target (T2T) for gout. However, the overall rate of good understanding of gout was only 6.5%, a basic knowledge of gout was 55.6%, and understanding about gout diagnosis and treatment was only 11.1%. The general practitioners’ understanding of basic concepts related to gout indicated that CME could improve their understanding (P < 0.05). An analysis of the general practitioners’ rate of comprehension of gout diagnosis and treatment showed that education level, CME, and familiarity with T2T could improve understandings of gout diagnosis and treatment (P < 0.05). Conclusion: There are serious deficits in understandings about gout among general practitioners in the Tongzhou district of Beijing. Quality CME is needed to improve Chinese general practitioners’ management of gout.

1 March 2024 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
MLMin Liu
Min Liu
YDYun-Jiao Duan
Yun-Jiao Duan
YZYe Zhang
Ye Zhang
JYJun Yang
Jun Yang
BWBing Wei
Bing Wei
JWJUNYU WANG
JUNYU WANG
Objective: This study examines the effectiveness of MIP-3alpha and severity scores in determining the prognosis of elderly sepsis patients. Methods: From October 2020 to April 2021, a total of 171 elderly sepsis patients were admitted to the Emergency Department of the Shijingshan Branch of Beijing Chaoyang Hospital, Capital Medical University. According to the 28-day mortality rate, they were divided into two groups: survivors (48 cases) and deaths (123 cases). At admission, severity scores which are the Sequential Organ Failure Assessment (SOFA) and the Acute Physiology and Chronic Health Evaluation II (APACHE II) were calculated. The logistic regression was used to analyze the independent risk factors associated with 28-day mortality in elderly sepsis patients. The receiver operating characteristic (ROC) curve and area under the curve (AUC) were used to evaluate the value of MIP-3alpha, SOFA, and APACHE II in the evaluation of 28-day mortality in elderly sepsis patients. Results: MIP-3alpha, SOFA and APACHE II of the death group were significantly higher than those of the survival group (P < 0.05). Multivariate logistic regression analysis showed that MIP-3alpha, SOFA, APACHE II, and systolic blood pressure (SBP) were independent risk factors for 28-day mortality of senile sepsis (P < 0.05). Analysis of the ROC curve revealed that MIP-3alpha, SOFA, APACHE II had predictive value for the 28-day prognosis of senile sepsis (all P < 0.01). Combing with MIP-3alpha and SOFA showed better predictive ability (Z1 = 3.733, Z2 = 2.996, both P < 0.01), compared to detecting MIP-3alpha and SOFA alone. Conclusion: In senile sepsis, MIP-3alpha, SOFA, APACHE II and SBP are independent risk factors for 28-day mortality. The combination of MIP-3alpha and SOFA can further enhance the predictive value of 28-day mortality in patients with senile sepsis and provide some reference value for the evaluation and treatment of senile sepsis.

1 January 2026 in Journal of Inflammation Research
Verified
Journal Article
Open access
MLMin Liu
Min Liu
RSRui Shao
Rui Shao
BLBo Liu
Bo Liu
ZTZiren Tang
Ziren Tang
The assessment of neurological prognosis in patients after return of spontaneous circulation (ROSC) following cardiopulmonary resuscitation (CPR) is a critical challenge in critical care medicine. Current prognostic tools (eg, clinical scales, imaging, or traditional biomarkers) have limitations in early accuracy and specificity, leading to uncertainties in treatment decision-making and prognostic communication. Presepsin (soluble CD14 subtype), an emerging inflammation- and infection-related biomarker, has gained increasing attention due to its potential association with post-CPR neurological injury and functional recovery. To address the lack of a systematic synthesis of evidence in this field, this narrative review aims to summarize the biological characteristics of presepsin, its role in neurological prognostic assessment post-CPR, and the underlying mechanisms linking presepsin to neuroinflammation and brain injury. We conducted a narrative synthesis of clinical studies retrieved from PubMed, Embase, and Cochrane Library up to (December 2025, focusing on studies correlating presepsin levels with validated neurological outcome scales. Core findings from synthesized evidence indicate that elevated presepsin levels, particularly within 24–72 hours after return of ROSC, show a consistent and significant association with poor neurological outcome (Cerebral Performance Category (CPC) 3–5) and higher mortality, and presepsin may serve as an independent prognostic factor complementary to existing tools. Major clinical implications include presepsin’s potential utility in multimodal prognostic protocols, aiding in early and more accurate outcome prediction. However, significant research gaps persist, including a lack of large-scale, multicenter validation studies, standardized measurement timepoints, and consensus on optimal cutoff values. In conclusion, current evidence supports presepsin as a promising inflammatory biomarker for neurological prognostication after cardiac arrest (CA). Future research must prioritize prospective validation in diverse cohorts and investigate its dynamic changes to establish its definitive role in clinical decision-making.